MRK
Merck & Co. Soars in Q3 2026: Record Revenue, Landmark Clinical Milestones
Merck & Co., a leading pharmaceutical company, has reported impressive third-quarter results for 2026, with revenue hitting $18.1 billion. The company's strong performance is driven by the success of new products, particularly in oncology and animal health. In a conference call on October 29, 2026, Merck &